These findings are in line with previous reports concerning SRSF1 expression in other solid tumors, including gliomas and lung cancer, in which its overexpression has been linked to a higher malignancy grade and poorer survival [19,20,21,22,23,24]. Here, SRSF1 is linked to central nervous system cancer.